However, there are limitations in this study, namely, the failure to clarify whether MINDY1 is an independent prognostic factor in HCC patients, and to detect the effects of MINDY1 and PD-L1 on tumor growth in mice with liver cancer transplantation. This evidence concerns the gene MINDY1 and hepatocellular carcinoma.